Maravai LifeSciences Holdings Cash on Hand 2019-2025 | MRVI
Maravai LifeSciences Holdings cash on hand from 2019 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| Maravai LifeSciences Holdings Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2024 | $322 |
| 2023 | $575 |
| 2022 | $632 |
| 2021 | $551 |
| 2020 | $236 |
| 2019 | $25 |
| 2018 | $22 |
| Maravai LifeSciences Holdings Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2025-03-31 | $285 |
| 2024-12-31 | $322 |
| 2024-09-30 | $578 |
| 2024-06-30 | $573 |
| 2024-03-31 | $562 |
| 2023-12-31 | $575 |
| 2023-09-30 | $580 |
| 2023-06-30 | $580 |
| 2023-03-31 | $628 |
| 2022-12-31 | $632 |
| 2022-09-30 | $617 |
| 2022-06-30 | $551 |
| 2022-03-31 | $431 |
| 2021-12-31 | $551 |
| 2021-09-30 | $548 |
| 2021-06-30 | $375 |
| 2021-03-31 | $248 |
| 2020-12-31 | $236 |
| 2020-09-30 | |
| 2020-06-30 | |
| 2020-03-31 | |
| 2019-12-31 | $25 |
| 2018-12-31 | $22 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.563B | $0.259B |
| Maravai LifeSciences Holdings Inc. is a life sciences company providing products for the development of drug therapies, diagnostics, novel vaccines and support research on human diseases. The company offer products and services in the fields of nucleic acid synthesis, bioprocess impurity detection and analysis, protein labeling and detection to biopharmaceutical, vaccine, diagnostics and cell and gene therapy companies. Maravai LifeSciences Holdings Inc. is based in SAN DIEGO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.693B | 27.62 |
| Boston Scientific (BSX) | United States | $154.617B | 38.71 |
| Stryker (SYK) | United States | $145.191B | 30.36 |
| EssilorLuxottica (ESLOY) | France | $128.660B | 0.00 |
| Medtronic (MDT) | Ireland | $104.194B | 14.77 |
| Haleon (HLN) | United Kingdom | $50.678B | 28.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.121B | 0.00 |
| ResMed (RMD) | United States | $35.889B | 26.96 |
| GE HealthCare Technologies (GEHC) | United States | $32.579B | 15.47 |
| Agilent Technologies (A) | United States | $31.612B | 20.53 |
| Terumo (TRUMY) | Japan | $27.743B | 36.03 |
| Insulet (PODD) | United States | $22.770B | 89.38 |
| Koninklijke Philips (PHG) | Netherlands | $21.553B | 15.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.259B | 11.73 |
| Baxter (BAX) | United States | $15.693B | 11.72 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.530B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.236B | 21.70 |
| Lantheus Holdings (LNTH) | United States | $5.132B | 12.95 |
| Prestige Consumer Healthcare (PBH) | United States | $4.168B | 18.62 |
| Perrigo (PRGO) | Ireland | $3.726B | 9.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.248B | 14.79 |
| ICU Medical (ICUI) | United States | $3.162B | 23.32 |
| Envista Holdings (NVST) | United States | $3.141B | 26.10 |
| GN Store Nord (GNNDY) | Denmark | $2.200B | 18.22 |
| QuidelOrtho (QDEL) | United States | $2.144B | 14.74 |
| LeMaitre Vascular (LMAT) | United States | $1.830B | 40.91 |
| AtriCure (ATRC) | United States | $1.660B | 0.00 |
| Acuren (TIC) | United States | $1.336B | 0.00 |
| Neogen (NEOG) | United States | $1.326B | 16.97 |
| AdaptHealth (AHCO) | United States | $1.225B | 12.44 |
| Kestra Medical Technologies (KMTS) | United States | $1.174B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.103B | 24.81 |
| BioLife Solutions (BLFS) | United States | $1.062B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.69 |
| InMode (INMD) | Israel | $0.910B | 9.17 |
| CeriBell (CBLL) | United States | $0.621B | 0.00 |
| Evolus (EOLS) | United States | $0.600B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.593B | 0.00 |
| Valneva SE (VALN) | France | $0.533B | 0.00 |
| Owens & Minor (OMI) | United States | $0.504B | 4.18 |
| Capricor Therapeutics (CAPR) | United States | $0.486B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.453B | 0.00 |
| Surmodics (SRDX) | United States | $0.418B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.366B | 0.00 |
| SNDL (SNDL) | Canada | $0.342B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.324B | 11.91 |
| Aurora Cannabis (ACB) | Canada | $0.310B | 55.20 |
| Viemed Healthcare (VMD) | United States | $0.260B | 21.90 |
| Sanara MedTech (SMTI) | United States | $0.257B | 0.00 |
| ZimVie (ZIMV) | United States | $0.245B | 11.14 |
| Cerus (CERS) | United States | $0.242B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.240B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.236B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.211B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.207B | 0.00 |
| Quanterix (QTRX) | United States | $0.205B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.50 |
| Biote (BTMD) | United States | $0.193B | 5.43 |
| Omeros (OMER) | United States | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| High Tide (HITI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.30 |
| Exagen (XGN) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.135B | 16.62 |
| Jin Medical (ZJYL) | China | $0.119B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.119B | 0.00 |
| Agape ATP (ATPC) | $0.093B | 0.00 | |
| Fonar (FONR) | United States | $0.089B | 11.48 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.070B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.052B | 0.00 |
| Modular Medical (MODD) | United States | $0.047B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.45 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.031B | 41.74 |
| Safety Shot (SHOT) | United States | $0.026B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |